ArticleFrontiers in immunology2023

Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors.

Lena Immisch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.